Edgar Filing: NVE CORP /NEW/

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2016

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to

Commission File Number: 000-12196

NVE CORPORATION
(Exact name of registrant as specified in its charter)

Minnesota		41-1424202
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

11409 Valley View Road, Eden Prairie, Minnesota		55344
(Address of principal executive offices)		(Zip Code)

(952) 829-9217
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

[X] Yes [ ] No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

[X] Yes [ ] No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]	Accelerated filer [X]
Non-accelerated filer [ ] (Do not check if a smaller reporting company)	Smaller reporting company [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Common Stock, $0.01 Par Value – 4,837,010 shares outstanding as of January 13, 2017

NVE CORPORATION
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION

     Item 1. Financial Statements

          Balance Sheets

          Statements of Income for the Quarters Ended December 31, 2016 and 2015

          Statements of Comprehensive Income for the Quarters Ended December 31, 2016 and 2015

          Statements of Income for the Nine Months Ended December 31, 2016 and 2015

          Statements of Comprehensive Income for the Nine Months Ended December 31, 2016 and 2015

          Statements of Cash Flows

          Notes to Financial Statements

     Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     Item 3. Quantitative and Qualitative Disclosures About Market Risk

     Item 4. Controls and Procedures

PART II. OTHER INFORMATION

     Item 1. Legal Proceedings

     Item 1A. Risk Factors

     Item 4. Mine Safety Disclosures

     Item 6. Exhibits

SIGNATURES

Table of Contents

PART I–FINANCIAL INFORMATION

Item 1. Financial Statements.

NVE CORPORATION
BALANCE SHEETS

	(Unaudited) December 31, 2016			March 31, 2016*
ASSETS
Current assets
Cash and cash equivalents	$	3,799,188		$	7,534,593
Marketable securities, short-term		24,655,206			19,697,384
Accounts receivable, net of allowance for uncollectible accounts of $15,000		1,461,659			2,244,086
Inventories		3,162,478			3,205,233
Prepaid expenses and other assets	751,433			734,524
Total current assets		33,829,964			33,415,820
Fixed assets
Machinery and equipment		9,020,726			8,840,033
Leasehold improvements	1,559,719			1,539,965
		10,580,445			10,379,998
Less accumulated depreciation and amortization	9,281,531			8,688,285
Net fixed assets		1,298,914			1,691,713
Long-term deferred tax assets	446,949			51,188
Marketable securities, long-term	59,668,735			65,695,335
Total assets	$	95,244,562		$	100,854,056

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable	$	358,530		$	317,990
Accrued payroll and other	679,040			556,674
Deferred revenue	-			714,805
Total current liabilities		1,037,570			1,589,469

Shareholders’ equity
Common stock, $0.01 par value, 6,000,000 shares authorized; 4,837,010 issued and outstanding as of December 31, 2016 and 4,835,010 issued and outstanding as of March 31, 2016		48,370			48,350
Additional paid-in capital		19,319,679			19,205,682
Accumulated other comprehensive (loss) income		(135,709	)		451,359
Retained earnings	74,974,652			79,559,196
Total shareholders’ equity	94,206,992			99,264,587
Total liabilities and shareholders’ equity	$	95,244,562		$	100,854,056

*The March 31, 2016 Balance Sheet is derived from the audited financial statements contained in our Annual Report on Form 10-K for the fiscal year ended March 31, 2016.

See accompanying notes.

3

Table of Contents

NVE CORPORATION
STATEMENTS OF INCOME
(Unaudited)

	Quarter Ended Dec. 31
	2016		2015
Revenue
Product sales	$	7,116,931	$	5,025,041
Contract research and development	345,748		990,974
Total revenue		7,462,679		6,016,015
Cost of sales	1,502,848		1,508,361
Gross profit		5,959,831		4,507,654
Expenses
Selling, general, and administrative		384,322		406,676
Research and development	826,816		738,657
Total expenses	1,211,138		1,145,333
Income from operations		4,748,693		3,362,321
Interest income	395,207		468,367
Income before taxes		5,143,900		3,830,688
Provision for income taxes	1,660,156		1,253,237
Net income	$	3,483,744	$	2,577,451
Net income per share – basic	$	0.72	$	0.53
Net income per share – diluted	$	0.72	$	0.53
Cash dividends declared per common share	$	1.00	$	1.00
Weighted average shares outstanding
Basic		4,836,336		4,844,845
Diluted		4,839,777		4,846,970

STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)

	Quarter Ended Dec. 31
	2016			2015
Net income	$	3,483,744		$	2,577,451
Unrealized loss from marketable securities, net of tax	(571,862		)	(321,222		)
Comprehensive income	$	2,911,882		$	2,256,229

See accompanying notes.

4

Table of Contents

NVE CORPORATION
STATEMENTS OF INCOME
(Unaudited)

	Nine Months Ended Dec. 31
	2016		2015
Revenue
Product sales	$	19,782,529	$	19,197,578
Contract research and development	1,690,461		2,419,113
Total revenue		21,472,990		21,616,691
Cost of sales	4,628,840		5,146,803
Gross profit		16,844,150		16,469,888
Expenses
Selling, general, and administrative		1,117,925		1,416,071
Research and development	2,353,372		2,048,620
Total expenses	3,471,297		3,464,691
Income from operations		13,372,853		13,005,197
Interest income	1,263,924		1,422,696
Income before taxes		14,636,777		14,427,893
Provision for income taxes	4,715,291		4,736,421
Net income	$	9,921,486	$	9,691,472
Net income per share – basic	$	2.05	$	2.00
Net income per share – diluted	$	2.05	$	2.00
Cash dividends declared per common share	$	3.00	$	3.00
Weighted average shares outstanding
Basic		4,835,639		4,853,970
Diluted		4,837,815		4,857,103

STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)

	Nine Months Ended Dec. 31
	2016			2015
Net income	$	9,921,486		$	9,691,472
Unrealized loss from marketable securities, net of tax	(587,068		)	(665,090		)
Comprehensive income	$	9,334,418		$	9,026,382

See accompanying notes.

5

Table of Contents

NVE CORPORATION
STATEMENTS OF CASH FLOWS
(Unaudited)

	Nine Months Ended Dec. 31
	2016			2015
OPERATING ACTIVITIES
Net income	$	9,921,486		$	9,691,472
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		868,218			628,186
Stock-based compensation		22,000			21,160
Excess tax deficiencies (benefits)		293			(352,294	)
Deferred income taxes		(61,076	)		305,391
Changes in operating assets and liabilities:
Accounts receivable		782,427			1,210,285
Inventories		42,755			633,581
Prepaid expenses and other assets		(16,909	)		(328,655	)
Accounts payable and accrued expenses		162,906			(625,422	)
Deferred revenue		(714,805	)		714,805
Net cash provided by operating activities		11,007,295			11,898,509

INVESTING ACTIVITIES
Purchases of fixed assets		(200,447	)		(177,449	)
Purchases of marketable securities		(11,528,240	)		(9,613,052	)
Proceeds from maturities of marketable securities		11,400,000			7,825,000
Net cash used in investing activities		(328,687	)		(1,965,501	)

FINANCING ACTIVITIES
Proceeds from sale of common stock		92,310			292,909
Excess tax (deficiencies) benefits		(293	)		352,294
Repurchase of common stock		-			(1,851,290	)
Payment of dividends to shareholders		(14,506,030	)		(14,570,019	)
Net cash used in financing activities		(14,414,013	)		(15,776,106	)

Decrease in cash and cash equivalents		(3,735,405	)		(5,843,098	)
Cash and cash equivalents at beginning of period	7,534,593			9,437,262

Cash and cash equivalents at end of period	$	3,799,188		$	3,594,164

Supplemental disclosures of cash flow information:
Cash paid during the period for income taxes	$	4,720,000		$	4,490,000

See accompanying notes.

6

Table of Contents

NVE CORPORATION
NOTES TO FINANCIAL STATEMENTS
(Unaudited)

NOTE 1. DESCRIPTION OF BUSINESS
     We develop and sell devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information.

NOTE 2. INTERIM FINANCIAL INFORMATION
     The accompanying unaudited financial statements of NVE Corporation are prepared consistent with accounting principles generally accepted in the United States and in accordance with Securities and Exchange Commission rules and regulations. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal and recurring adjustments, necessary for a fair presentation of the financial statements. Although we believe that the disclosures are adequate to make the information presented not misleading, it is suggested that these unaudited financial statements be read in conjunction with the audited financial statements and the notes included in our latest annual financial statements included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2016. The results of operations for the quarter or nine months ended December 31, 2016 are not necessarily indicative of the results that may be expected for the full fiscal year ending March 31, 2017.

NOTE 3. RECENTLY ISSUED ACCOUNTING STANDARDS
     In May 2014, the Financial Accounting Standards Board (FASB) issued a new standard based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. It also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The guidance permits two methods of adoption: retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application. The new standard is effective for fiscal years beginning after December 15, 2017, including interim periods within that reporting period, which will be our first quarter of fiscal 2019. We are currently evaluating the impact that the adoption of the standard will have on our financial statements and have not made any decision on the method of adoption.

     The FASB has issued ASUs through No. 2016-20. We have reviewed each recently issued ASU, and the adoption of each ASU that is applicable to us, other than as noted above, will not have a significant impact on our financial statements.

NOTE 4. NET INCOME PER SHARE
     Net income per basic share is computed based on the weighted-average number of common shares issued and outstanding during each period. Net income per diluted share amounts assume exercise of all stock options. Stock options totaling 4,000 for the quarter ended December 31, 2016, 6,000 for the nine months ended December 31, 2016, 10,000 for the quarter ended December 31, 2015, and 4,000 for the nine months ended December 31, 2015 were not included in the computation of diluted earnings per share because the exercise prices were greater than the market price of the common stock.

     The following tables show the components of diluted shares:

	Quarter Ended Dec. 31
	2016	2015
Weighted average common shares outstanding – basic	4,836,336	4,844,845
Dilutive effect of stock options	3,441	2,125
Shares used in computing net income per share – diluted	4,839,777	4,846,970

	Nine Months Ended Dec. 31
	2016	2015
Weighted average common shares outstanding – basic	4,835,639	4,853,970
Dilutive effect of stock options	2,176	3,133
Shares used in computing net income per share – diluted	4,837,815	4,857,103

Table of Contents

NOTE 5. MARKETABLE SECURITIES
Marketable securities with remaining maturities less than one year are classified as short-term, and those with remaining maturities greater than one year are classified as long-term. The fair value of our marketable securities as of December 31, 2016, by maturity, were as follows:

Total			<1 Year			1–3 Years			3–5 Years
$	84,323,941		$	24,655,206		$	36,400,319		$	23,268,416

As of December 31 and March 31, 2016, our marketable securities were as follows:

	As of December 31, 2016									As of March 31, 2016
	Adjusted Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Market Value		Adjusted Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Market Value
Corporate bonds	$	83,222,388	$	123,045	$	(334,944	)	$	83,010,489	$	83,339,487	$	717,206	$	(10,824	)	$	84,045,869
Municipal bonds	1,314,695		-		(1,243		)	1,313,452		1,344,328		2,522		-			1,346,850
Total	$	84,537,083	$	123,045	$	(336,187	)	$	84,323,941	$	84,683,815	$	719,728	$	(10,824	)	$	85,392,719

Nine securities were in an unrealized loss position as of December 31, 2016. The following table shows the gross unrealized losses and fair value of our investments with unrealized losses, aggregated by investment category and length of time that individual securities had been in a continuous unrealized loss position as of December 31 and March 31, 2016:

		Less Than 12 Months					12 Months or Greater					Total
		Fair Market Value		Gross Unrealized Losses			Fair Market Value		Gross Unrealized Losses			Fair Market Value		Gross Unrealized Losses
As of December 31, 2016
	Corporate bonds	$	30,147,097	$	(334,944	)	$	-	$	-		$	30,147,097	$	(334,944	)
	Municipal bonds	1,313,452		(1,243		)	-		-			1,313,452		(1,243		)
	Total	$	31,460,549	$	(336,187	)	$	-	$	-		$	31,460,549	$	(336,187	)
As of March 31, 2016
	Corporate bonds	$	3,003,606	$	(6,703	)	$	2,599,870	$	(4,121	)	$	5,603,476	$	(10,824	)
	Municipal bonds	-		-			-		-			-		-
	Total	$	3,003,606	$	(6,703	)	$	2,599,870	$	(4,121	)	$	5,603,476	$	(10,824	)

Because we expect to recover the cost basis of investments held, we do not consider any of our marketable securities to be impaired as of December 31, 2016.

Table of Contents

NOTE 6. INVENTORIES
Inventories consisted of the following:

	Dec. 31, 2016		March 31, 2016
Raw materials	$	763,869	$	810,987
Work in process		1,779,504		1,653,800
Finished goods	619,105		740,446
Total inventories	$	3,162,478	$	3,205,233

NOTE 7. STOCK-BASED COMPENSATION
      Stock-based compensation expense was $22,000 for the first nine months of fiscal 2017, and $21,160 for the first nine months of fiscal 2016. The stock-based compensation expenses were due to the issuance of automatic stock options to our non-employee directors on their election or reelection to our Board.

NOTE 8. INCOME TAXES
     Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

     We had no unrecognized tax benefits as of December 31, 2016, and we do not expect any significant unrecognized tax benefits within 12 months of the reporting date. We recognize interest and penalties related to income tax matters in income tax expense. As of December 31, 2016 we had no accrued interest related to uncertain tax positions. The tax years 1999 and 2013 through 2015 remain open to examination by the major taxing jurisdictions to which we are subject.

NOTE 9. FAIR VALUE MEASUREMENTS
     Generally accepted accounting principles establish a framework for measuring fair value, provide a definition of fair value and prescribe required disclosures about fair-value measurements. Generally accepted accounting principles define fair value as the price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Generally accepted accounting principles utilize a valuation hierarchy for disclosure of fair value measurements. The categorization within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The categories within the valuation hierarchy are described as follows:

     Level 1 – Financial instruments with quoted prices in active markets for identical assets or liabilities. Our Level 1 financial instruments consist of publicly-traded marketable corporate debt securities, which are classified as available-for-sale. On the balance sheets, these securities are included in “Marketable securities, short term” and “Marketable securities, long term.” The fair value of our Level 1 marketable securities was $83,010,489 as of December 31, 2016 and $84,045,869 as of March 31, 2016.

     Level 2 – Financial instruments with quoted prices in active markets for similar assets or liabilities. Level 2 fair value measurements are determined using either prices for similar instruments or inputs that are either directly or indirectly observable, such as interest rates. We had one Level 2 financial instrument, a municipal debt security, which is classified as available-for-sale. The fair value of the Level 2 marketable security was $1,313,452 as of December 31, 2016 and $1,346,850 as of March 31, 2016. The security was included in “Marketable securities, short term” on the December 31, 2016 balance sheet, and “Marketable securities, long term” on the March 31, 2016 balance sheet.

     Level 3 – Inputs to the fair value measurement are unobservable inputs or valuation techniques. We do not have any financial assets or liabilities being measured at fair value that are classified as Level 3 financial instruments.

Table of Contents

NOTE 10. STOCK REPURCHASE PROGRAM
     On January 21, 2009 we announced that our Board of Directors authorized the repurchase of up to $2,500,000 of our Common Stock, and on August 27, 2015 we announced that our Board authorized $5,000,000 of additional repurchases. We did not repurchase any of our Common Stock under the program during the quarter ended December 31, 2016. The remaining authorization was $4,540,806 as of December 31, 2016. The Repurchase Program may be modified or discontinued at any time without notice.

NOTE 11. DIVIDENDS
     On January 18, 2017 we announced that our Board had declared a quarterly cash dividend of $1.00 per share of Common Stock to be paid February 28, 2017 to shareholders of record as of the close of business January 30, 2017.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-looking statements
     Some of the statements made in this Report or in the documents incorporated by reference in this Report and in other materials filed or to be filed by us with the Securities and Exchange Commission (“SEC”) as well as information included in verbal or written statements made by us constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to the safe harbor provisions of the reform act. Forward-looking statements may be identified by the use of the terminology such as may, will, expect, anticipate, intend, believe, estimate, should, or continue, or the negatives of these terms or other variations on these words or comparable terminology. To the extent that this Report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of NVE, you should be aware that our actual financial condition, operating results and business performance may differ materially from that projected or estimated by us in the forward-looking statements. We have attempted to identify, in context, some of the factors that we currently believe may cause actual future experience and results to differ from their current expectations. These differences may be caused by a variety of factors, including but not limited to our reliance on several large customers for a significant percentage of revenue, uncertainties related to the economic environments in the industries we serve, uncertainties related to future contract research and development revenue, uncertainties related to future stock repurchases and dividend payments, and other specific risks that may be alluded to in this Report or in the documents incorporated by reference in this Report.

     Further information regarding our risks and uncertainties are contained in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended March 31, 2016.

General
     NVE Corporation, referred to as NVE, we, us, or our, develops and sells devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store and transmit information. We manufacture high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. We have also licensed our spintronic magnetoresistive random access memory technology, commonly known as MRAM.

Critical accounting policies
     A description of our critical accounting policies is provided in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended March 31, 2016. As of December 31, 2016 our critical accounting policies and estimates continued to include investment valuation, inventory valuation, and deferred tax assets estimation.

Table of Contents

Quarter ended December 31, 2016 compared to quarter ended December 31, 2015
The table shown below summarizes the percentage of revenue and quarter-to-quarter changes for various items:

	Percentage of Revenue Quarter Ended Dec. 31				Quarter- to-Quarter Change
	2016		2015		Quarter- to-Quarter Change
Revenue
Product sales	95.4	%	83.5	%	41.6	%
Contract research and development	4.6	%	16.5	%	(65.1	)%
Total revenue	100.0	%	100.0	%	24	%
Cost of sales	20.1	%	25.1	%	(0.4	)%
Gross profit	79.9	%	74.9	%	32.2	%
Expenses
Selling, general, and administrative	5.2	%	6.7	%	(5.5	)%
Research and development	11.1	%	12.3	%	11.9	%
Total expenses	16.3	%	19.0	%	5.7	%
Income from operations	63.6	%	55.9	%	41.2	%
Interest income	5.3	%	7.8	%	(15.6	)%
Income before taxes	68.9	%	63.7	%	34.3	%
Provision for income taxes	22.2	%	20.9	%	32.5	%
Net income	46.7	%	42.8	%	35.2	%

     Total revenue for the quarter ended December 31, 2016 (the third quarter of fiscal 2017) increased 24% compared to the quarter ended December 31, 2015 (the third quarter of fiscal 2016). The increase was due to a 42% increase in product sales, partially offset by a 65% decrease in contract research and development revenue.

     The increase in product sales from the prior-year quarter was due to new customers and increased purchase volume by existing customers. The decrease in contract research and development revenue for the third quarter of fiscal 2017 was due to the completion of certain contracts.

     Gross profit margin increased to 80% of revenue for the third quarter of fiscal 2017 compared to 75% for the third quarter of fiscal 2016, due to more profitable revenue and product sales mixes.

     Total expenses increased 6% for the third quarter of fiscal 2017 compared to the third quarter of fiscal 2016, due to a 12% increase in research and development expense, partially offset by a 5% decrease in selling, general, and administrative expense. The increase in research and development expense was due to an increase in new product development activities. The decrease in selling, general, and administrative expense was primarily due to decreased sales commissions.

     Interest income for the third quarter of fiscal 2017 decreased 16% due to a decrease in marketable securities and a decrease in the average interest rates on those securities.

     The provision for income taxes was $1,660,156 for the third quarter of fiscal 2017 compared to $1,253,237 for the third quarter of fiscal 2016. The effective tax rate was 32% of income before taxes for the third quarter of fiscal 2017 compared to 33% for the third quarter of fiscal 2016.

     The 35% increase in net income in the third quarter of fiscal 2017 compared to the prior-year quarter was primarily due to increased product sales, increased gross profit margin, and decreased selling, general, and administrative expense, partially offset by decreased contract research and development revenue, increased research and development expense, and decreased interest income.

Table of Contents

Nine months ended December 31, 2016 compared to nine months ended December 31, 2015
The table shown below summarizes the percentage of revenue and period-to-period changes for various items:

	Percentage of Revenue Nine Months Ended Dec. 31				Period- to-Period Change
	2016		2015		Period- to-Period Change
Revenue
Product sales	92.1	%	88.8	%	3.0	%
Contract research and development	7.9	%	11.2	%	(30.1	)%
Total revenue	100.0	%	100.0	%	(0.7	)%
Cost of sales	21.6	%	23.8	%	(10.1	)%
Gross profit	78.4	%	76.2	%	2.3	%
Expenses
Selling, general, and administrative	5.2	%	6.5	%	(21.1	)%
Research and development	10.9	%	9.5	%	14.9	%
Total expenses	16.1	%	16.0	%	0.2	%
Income from operations	62.3	%	60.2	%	2.8	%
Interest income	5.9	%	6.5	%	(11.2	)%
Income before taxes	68.2	%	66.7	%	1.4	%
Provision for income taxes	22.0	%	21.9	%	(0.4	)%
Net income	46.2	%	44.8	%	2.4	%

     Total revenue for the nine months ended December 31, 2016 (the first nine months of fiscal 2017) decreased 1% compared to the nine months ended December 31, 2015 (the first nine months of fiscal 2016). The decrease was due to a 30% decrease in contract research and development revenue, partially offset by a 3% increase in product sales.

     The increase in product sales from the prior-year period was due to new customers. The decrease in contract research and development revenue for the first nine months of fiscal 2017 was due to the completion of certain contracts.

     Gross profit margin increased to 78% of revenue for the first nine months of fiscal 2017 compared to 76% for the first nine months of fiscal 2016, due to a more profitable revenue mix.

     Total expenses were approximately unchanged for the first nine months of fiscal 2017 compared to the first nine months of fiscal 2016, as a 15% increase in research and development expense was offset by a 21% decrease in selling, general, and administrative expense. The increase in research and development expense was due to increased new product development activities. The decrease in selling, general, and administrative expense was primarily due to decreased sales commissions.

     Interest income for the first nine months of fiscal 2017 decreased 11% due to a decrease in marketable securities and a decrease in the average interest rates on those securities.

     The 2% increase in net income in the first nine months of fiscal 2017 compared to the prior-year quarter was primarily due to increased gross profit margin partially offset by decreased interest income.

Table of Contents

Liquidity and capital resources

Overview
     Cash and cash equivalents were $3,799,188 as of December 31, 2016 compared to $7,534,593 as of March 31, 2016. The $3,735,405 decrease in cash and cash equivalents during the nine months ended December 31, 2016 was due to $14,414,013 net cash used in financing activities and $328,687 net cash used in investing activities, partially offset by $11,007,295 in net cash provided by operating activities. We currently believe our working capital and cash generated from operations will be adequate for our needs at least for the next 12 months.

Operating Activities
     Accounts receivable as of December 31, 2016 decreased $782,427 compared to March 31, 2016, primarily due to the timing of sales to and payments from certain customers. Deferred revenue decreased $714,805 because we delivered the products associated with deferred revenue.

Investing Activities
     Net cash used in investing activities in the first nine months of fiscal 2017 was due to $200,447 in purchases of fixed assets and $11,528,240 of marketable security purchases, partially offset by $11,400,000 of marketable security maturities.

Financing Activities
     Net cash used in financing activities in the first nine months of fiscal 2017 was primarily due to $14,506,030 of cash dividends paid to shareholders. In addition to dividends paid in the first nine months of fiscal 2017, on January 18, 2017 we announced that our Board had declared a cash quarterly dividend of an additional $1.00 per share of common stock, or $4,837,010 based on shares outstanding as of January 13, 2017, to be paid February 28, 2017. We plan to fund such dividends through cash provided by operating activities and proceeds from maturities of marketable securities. All future dividends will be subject to Board approval and subject to the company’s results of operations, cash and marketable security balances, estimates of future cash requirements, and other factors the Board may deem relevant. Furthermore, dividends may be modified or discontinued at any time without notice.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.
     As discussed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2016, we are exposed to financial market risks, primarily marketable securities and, to a lesser extent, changes in currency exchange rates.

Marketable Securities
     The primary objective of our investment activities is to preserve principal while at the same time maximizing after-tax yields without significantly increasing risk. To achieve this objective, we maintain our portfolio of cash equivalents and marketable securities in securities including municipal obligations, corporate obligations, and money market funds. Short-term and long-term marketable securities are generally classified as available-for-sale and consequently are recorded on the balance sheet at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income or loss, net of estimated tax. Our marketable securities as of December 31, 2016 had remaining maturities between one month and 241 weeks. Marketable securities had a market value of $84,323,941 as of December 31, 2016, representing approximately 89% of our total assets. We have not used derivative financial instruments in our investment portfolio.

Table of Contents

Item 4. Controls and Procedures.
Disclosure Controls and Procedures
Management, with the participation of the Chief Executive Officer and Chief Financial Officer, has performed an evaluation of our disclosure controls and procedures that are defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this Report. This evaluation included consideration of the controls, processes, and procedures that are designed to ensure that information required to be disclosed by us in the reports we file under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2016, our disclosure controls and procedures were effective.

Changes in Internal Controls
During the quarter ended December 31, 2016, there was no change in our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II–OTHER INFORMATION

Item 1. Legal Proceedings.
     In the ordinary course of business we may become involved in litigation. At this time we are not aware of any material pending or threatened legal proceedings or other proceedings contemplated by governmental authorities that we expect would have a material adverse impact on our future results of operation and financial condition.

Item 1A. Risk Factors.
     There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2016.

Item 4. Mine Safety Disclosures.
     Not applicable.

Table of Contents

Item 6. Exhibits.

Exhibit #	Description

31.1	Certification by Daniel A. Baker pursuant to Rule 13a-14(a)/15d-14(a).
31.2	Certification by Curt A. Reynders pursuant to Rule 13a-14(a)/15d-14(a).
32	Certification by Daniel A. Baker and Curt A. Reynders pursuant to 18 U.S.C. Section 1350.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	NVE CORPORATION
	(Registrant)

January 18, 2017	/s/ DANIEL A. BAKER
Date	Daniel A. Baker
	President and Chief Executive Officer

January 18, 2017	/s/ CURT A. REYNDERS
Date	Curt A. Reynders
	Chief Financial Officer